Shows very promising results in attacking specific types of pancreatic cancer....
Specific HALO agent (PEGH20) increases the permeability of the membrane of the cancer cells, allowing the primary cancer drug better entry to attack the disease. Studied in other types of cancer as well, including lung, and shown to be equally effective in extending life.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.